Good Company - R&D AstraZeneca Employee Review

4.0
14 Oct 2021
Recommend
CEO approval
Business outlook

Pros

Global interface promote more diverse culture

Cons

workload and &resource limitation could be a challenge

Explore other reviews about AstraZeneca

5.0
25 June 2026
Recommend
CEO approval
Business outlook

Pros

Good products, great oncology pipeline

Cons

Global leaders moving to US that have limited understanding of US environment

4.0
29 June 2026
Recommend
CEO approval
Business outlook

Pros

Lots to learn with multiple launches and focus on AI

Cons

heavy middle layer slows down decision making

See reviews by: Helpful|Rating|Date|All